European Medicines Agency (EMA) Validates Atara Biotherapeutics’ Marketing Authorization Application
November 30, 2021
- News
Atara Biotherapeutics announced that the Marketing Authorization Application (MAA) for tabelecleucel (tab-cel®) has been fully validated by the European Medicines Agency (EMA).